NanoVibronix, Inc. Share Price

Equities

NAOV

US63008J6038

Medical Equipment, Supplies & Distribution

We are working hard...
  • We are working hard to come back as soon as possible.
  • Nous travaillons dur pour revenir au plus vite.
  • Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
  • Estamos trabajando duro para volver lo antes posible.
  • Stiamo lavorando sodo per tornare il prima possibile.
  • Wij werken hard om zo snel mogelijk weer terug te zijn.
503 Backend fetch failed
We are working hard...
  • We are working hard to come back as soon as possible.
  • Nous travaillons dur pour revenir au plus vite.
  • Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
  • Estamos trabajando duro para volver lo antes posible.
  • Stiamo lavorando sodo per tornare il prima possibile.
  • Wij werken hard om zo snel mogelijk weer terug te zijn.
503 Backend fetch failed
Sales 2022 752K 59.98M Sales 2023 2.28M 182M Capitalization 2.35M 188M
Net income 2022 -5M -399M Net income 2023 -3M -239M EV / Sales 2022 7.49 x
Net cash position 2022 2.63M 210M Net cash position 2023 3.28M 261M EV / Sales 2023 -0.41 x
P/E ratio 2022
-1.31 x
P/E ratio 2023
-0.54 x
Employees 13
Yield 2022 *
-
Yield 2023
-
Free-Float 99.58%
More Fundamentals * Assessed data
Dynamic Chart
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
NanoVibronix, Inc. Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity CI
NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan CI
NanoVibronix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Investors Eye Fed Moves as US Futures Trend Lower in Friday's Premarket MT
NanoVibronix, Inc. Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff CI
NanoVibronix Files Registration Statement on Behalf of Selling Shareholders MT
NanoVibronix to Raise $5 Million Through Securities Placement MT
Top Midday Gainers MT
NanoVibronix, Inc. announced that it expects to receive $5 million in funding CI
NanoVibronix Says It's Working to Understand Implications of CMS Decision Related to PainShield Device MT
NanoVibronix, Inc. Applies for Inclusion of Uroshield Products in Nhs Prescription Services' Drug Tariff CI
NanoVibronix Extends Distribution Agreement With Ultra Pain Products for Ultrasound Therapy Devices; Shares Rise MT
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus CI
NanoVibronix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
More news
1 day+1.13%
1 week-5.19%
Current month-15.72%
1 month-15.72%
3 months-29.11%
6 months-7.39%
Current year-34.04%
More quotes
1 week
0.75
Extreme 0.75
0.80
1 month
0.70
Extreme 0.7
0.93
Current year
0.70
Extreme 0.7
1.52
1 year
0.70
Extreme 0.7
4.34
3 years
0.70
Extreme 0.7
83.80
5 years
0.70
Extreme 0.7
90.00
10 years
0.70
Extreme 0.7
170.00
More quotes
Managers TitleAgeSince
Founder 69 31/08/03
Chief Executive Officer 67 12/10/16
Director of Finance/CFO 67 02/02/15
Members of the board TitleAgeSince
Director/Board Member 72 26/04/15
Chairman 74 13/11/16
Director/Board Member 72 31/12/21
More insiders
We are working hard...
  • We are working hard to come back as soon as possible.
  • Nous travaillons dur pour revenir au plus vite.
  • Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
  • Estamos trabajando duro para volver lo antes posible.
  • Stiamo lavorando sodo per tornare il prima possibile.
  • Wij werken hard om zo snel mogelijk weer terug te zijn.
503 Backend fetch failed

Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm

More quotes
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
Calendar
More about the company
We are working hard...
  • We are working hard to come back as soon as possible.
  • Nous travaillons dur pour revenir au plus vite.
  • Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
  • Estamos trabajando duro para volver lo antes posible.
  • Stiamo lavorando sodo per tornare il prima possibile.
  • Wij werken hard om zo snel mogelijk weer terug te zijn.
503 Backend fetch failed